Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fore Kopi Indonesia Tbk. (FORE) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Fore Kopi Indonesia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Fore Kopi Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Fore Kopi Indonesia Tbk. trades at Rp615 (market cap 5.44T, 1.89M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Fore Kopi Indonesia Tbk. is far larger — about 32.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Fore Kopi Indonesia Tbk. is more actively traded (1.89M versus 71K). Which is the better fit depends on your goals.

FOREOBAT
Market Cap
5.44T167.37B
Volume
1.89M71K
Lot
18.9K710
Turnover
1.15B17.51M
Average Price
609.92246.63
Value
1.15B17.51M
Indicative Equilibrium Price
615246
Indicative Equilibrium Volume
1.29K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

FORE
View details
OBAT
View details

About Fore Kopi Indonesia Tbk.

PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.

Read more on FORE

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT